yuansensetech
CJC-1295 With DAC
CJC-1295 With DAC
4.0 / 5.0
(1) 1 total reviews
Couldn't load pickup availability
Product Description
Overview
CJC-1295 with DAC (Drug Affinity Complex), also known as DAC:GRF, is a synthetic analogue of growth hormone-releasing hormone (GHRH) developed by ConjuChem Biotechnologies. It is a tetrasubstituted 30-amino acid peptide analogue of GHRH, featuring a C-terminal Drug Affinity Complex moiety—a lysine linker conjugated to maleimidopropionic acid (MPA)—that enables selective binding to circulating albumin. This DAC technology significantly extends the compound's half-life to approximately 6–8 days, compared to ~30 minutes for the non-DAC version, establishing it as a long-acting GHRH analogue.
Mechanism of Action
CJC-1295 with DAC exerts its effects by binding to the growth hormone-releasing hormone receptor (GHRH-R) on somatotroph cells in the anterior pituitary gland. This receptor activation stimulates the synthesis and release of endogenous growth hormone (GH) in a sustained manner. The Drug Affinity Complex moiety enables the peptide to covalently bind to serum albumin following subcutaneous administration, protecting it from enzymatic degradation and significantly prolonging its half-life. The compound incorporates four amino acid substitutions—D-Ala at position 2 (to prevent DPP-IV cleavage), Gln at position 8 (to reduce asparagine rearrangement), Ala at position 15 (to enhance bioactivity), and Leu at position 27 (to prevent methionine oxidation)—which further enhance its stability and bioactivity.
Research Applications
- Growth Hormone Axis Research: Employed to study sustained GH secretion dynamics, GHRH receptor signaling, and the physiological regulation of the hypothalamic-pituitary-somatotropic axis.
- Metabolic and Body Composition Studies: Investigated for its role in lipid metabolism, protein synthesis, and body composition regulation.
- Endocrinology: Utilized to evaluate the effects of prolonged GH elevation on IGF-1 production and metabolic parameters.
- Aging and Gerontology Research: Explored in the context of age-related metabolic decline and healthy aging.
Product Specifications
CAS Number: 446262-90-4
PubChem CID: 16129620
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: 3,647.19–3,647.25 g/mol
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-LysLys(Maleimidopropionyl)-NH₂
Purity: ≥ 99%
Form: Lyophilized powder
Storage: Store at ≤ -20°C in a cool, dry place, protected from light and moisture
Solubility: Soluble in sterile water and DMSO; prepare working solutions per laboratory protocol
Share

Not bad at all, good for the price.
Research Use Only
This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.